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Leda BASSIT(1,2), Kioko TAKEI(2), Sumie HOSHINO-SHIMIZU(2), Anna S. NISHIYA(1), Ester C. SABINO(1), Rogério P. BASSITT(1), Roberto FOCACCIA(3),
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SUMMARY
The prevalence of TT virus (TTV) infection was investigated by Polymerase Chain Reaction (PCR) in low- (blood donors and
healthy children/adolescents) and high-risk (hemophiliacs) groups from São Paulo, Brazil. Primers based on the untranslated region
(UTR) of the viral genome proved to be much more ubiquitous, leading to much higher frequencies for both groups (> 81%) than the
earlier N22-PCR directed to the open reading frame 1 (blood donors, 5.5%, and hemophiliacs, 42.3%). The UTR-PCR also revealed
an interesting profile for healthy children/adolescents: very high prevalence at the early years and significant decrease in male teenagers.
The N22-PCR, in turn, demonstrated higher frequency in hemophiliacs treated with fresh blood products (58%), than in those treated
with virus-inactivated clotting factors (9.4%) and blood donors (5.5%).
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The novel unenveloped single-stranded DNA virus - TTV - has a high
infectious capacity by both parenteral and non-parenteral route and, yet
unclearly, has been associated with liver disease of unknown etiology5-7,10.
Early studies in Japan have been performed by PCR amplification
based on the N22 region within the open reading frame 1 of the viral
genome, and TTV infection was found in approximately 50% of non A-
G fulminant or chronic hepatitis patients compared to 12% of blood
donors5.
In contrast, when PCR primers were deduced from the untranslated
region (UTR), a much higher frequency (92%) was found in healthy
Japanese individuals11. In Brazil, early studies were based on the N22
region3,8 and, more recently, TTV genotyping was based on the UTR in
a population of healthy subjects4.
Our blood center at São Paulo is the largest of Latin America (c.a.
300,000 donations/year), and the present work is part of a monitoring
program to look for new blood-transmissible agents, which may be
hazardous for recipients. Therefore, soon after TTV was first identified,
we began an investigation on TTV infection in our blood donors and
hemophiliac population, and included children/adolescents without
history of blood transfusion or liver disease. TTV DNA was detected by
PCR amplification directed to the N22 region5 and UTR11.
The overall prevalence of TTV infection based on the UTR-PCR for
the blood donors and hemophiliacs was considerably higher than the
frequencies obtained for the N22 region, p < 0.02 and p < 0.05,
respectively (Table 1). This discrepancy may reflect the higher variability
in the region complementary to the primers employed for the N22-region
amplification, what would not be surprising in view of the high genetic
variability described for TTV1,6. However, one could argue that the N22-
PCR reaction is not as sensitive as the UTR-based one. This question
was well assessed by OKAMOTO et al., by means of a titration
experiment with two cloned TTV DNAs, in which the two sets of primers
(N22 and UTR) could, equally, detect nearly a single copy of the target
DNA6. Furthermore, another possible reason for the diverse figures
obtained for both UTR- and N22- based PCR reactions may be the
variation in viral titers among TTV strains in mixed infections, as
previously reported4,7.
The difference observed between the N22 estimates for blood donors
and hemophiliacs (p < 0.02; Table 1) can be explained by the high
parenteral exposure of the latter group. Furthermore, among hemophiliacs
who had been treated with fresh blood products, the frequency of the
N22-specific TTV was remarkably higher (58.0%; p < 0.001) than those
treated with virus-inactivated clotting factor (9.4%), those who were
not treated (11.1%) and blood donors (5.5%).
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Hence, it is possible that the acclaimed causal association between
TTV and some illness-related group is, at least in part, due to parenteral
exposure. Yet, there may be particular pathogenic variant(s) worth
searching for.
There was no significant difference between the TTV frequencies
observed for the three groups based on the UTR-PCR. Furthermore, the
distribution of TTV infection according to age within the studied groups
showed no significant difference, except for the children, which displayed
an interesting profile (Table 1). Prevalence was remarkably high in
children aging 2 to 4 years (95%) - decreasing continuously thereafter
and reaching a lower prevalence (47%; p < 0.02) in 15 to 17 year-old
male gender adolescents. The design and data of the present study allow
no explanation for this yet unknown phenomenon, that is contrary to
other report9; this discrepancy may be due to differences in origin and
size of the populations on both studies.
Our findings reinforce that TTV infection is widespread among
Brazilians, as so is for Japanese populations11. Moreover, the high
prevalence of the UTR-specific isolates found for both high- and low-
risk groups indicates that the parenteral route of transmission may not
play a major role for this infection and, as a rule, TTV is benign - requiring
no systematic screening in blood banks.
RESUMO
Nova estimativa da prevalência da infecção pelo vírus “TT”
(TTV) em populações de baixo e alto risco de São Paulo, Brasil
A prevalência da infecção pelo vírus “TT” (TTV) foi investigada
pela técnica da Reação da Polimerase em Cadeia (PCR) em grupos
considerados de baixo risco (doadores de sangue e crianças/adolescentes
saudáveis) e de alto risco de exposição parenteral (hemofílicos); todos
provenientes da cidade de São Paulo. Oligonucleotídeos empregados
como primers, homólogos à região não traduzível (UTR) do genoma
viral, mostraram-se muito mais universais, revelando frequências muito
mais altas em ambos os grupos (> 81%) do que os primers anteriormente
utilizados, baseados na região genômica traduzível “N22” (doadores de
sangue, 5,5%, e hemofílicos, 42,3%). O “PCR-UTR” também revelou
um perfil interessante em crianças/adolescentes saudáveis: alta
prevalência nos primeiros anos de vida e queda significativa em meninos
adolescentes. O “PCR-N22”, por sua vez, apresentou alta frequência em
hemofílicos que receberam derivados de sangue fresco (58%) relativa
àqueles que foram tratados com fatores de coagulação submetidos à
inativação viral (9,4%) e doadores de sangue (5,5%).
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Table 1
Frequency of TTV infection by N22- and UTR-PCR in different Brazilian
groups
N22 UTR-A
Group (age in years) Positive/total (%) Positive/total (%)
Blood donors* (16-61) 22/401 (5.5)a 168/197 (85.3)c
Hemophiliacs# (0.6-81) 55/130 (42.3)b 127 /130 (97.7)d
Children/adolescent‡ (2-17) not done 112/138 (81.2)
Male Female
(2-4) 12/13 (92.3) 8/8 (100)
(5 – 9) 17/20 (85.0) 21/24 (87.5)
(10 – 14) 18/21(85.7) 20/26 (76.9)
(15 – 17) 7/15 (46.7) 9/11 (88.8)
a vs b and a vs c p < 0.02; b vs d p < 0.05;  there was a significant decrease
between the 15 – 17 year-old group and the younger-male groups (p < 0.05).
There was no significant difference between the remaining group combinations.
*Serum samples collected from consecutive blood donors attending the FPS/
HSP, from July to August,1997. #Sera from hemophiliac patients attending the
Hemophiliac centers of FPS/HSP and the “Hospital das Clínicas” of the
University of São Paulo, from August, 1997, to August, 2000. ‡Sera from a
previous cross-sectional study to determine the prevalence of viral hepatitis in
the city of São Paulo2; samples collected at random from February to May,
1996. Statistical significance ( 95%) was analyzed by the Fisher´s exact test.
